| |
 Click here to view all events relating to Finance, M&A | |
 Click here to view all interviews relating to Finance, M&A | |
| Through The Reimbursement Barriers
| | Pharmaceutical Executive Europe | Brian Lovatt looks at how drug companies involved in oncology can meet their pricing and reimbursement objectives as NICE-style barriers start to rise across Europe. |
| | Streamlining Synergies
| | Pharmaceutical Executive Europe | | Discussing the importance of post-merger integration and synergy management in the generics industry. |
| | A Year in Pharma
| | Pharmaceutical Executive Europe | | Sarah Houlton outlines the deals, collaborations and controversies that shaped the pharmaceutical industry in 2007, and examines how the land lies as we prepare for 2008. |
| | Understanding the Chinese Market
| China's pharmaceutical market place may have been booming of late, but companies wishing to sustain growth in the country must ensure their intelligence is up to the minute.
| | Pharmaceutical Executive Europe | | China's pharmaceutical market place may have been booming of late, but companies wishing to sustain growth in the country must ensure their intelligence is up to the minute, report Songjun Luo and Brian Chapman. |
| | The Middleweight Challenge
| Although the industry experienced solid growth in 2006, the real action was among the mid-size players, according to Pharm Exec's annual look at the world's top 50 pharma companies.
| | Pharmaceutical Executive Europe | | Pfizer, Pfizer, Pfizer. Depending on your point of view, it's ironic, inspiring, or merely interesting that the company that staggered out of 2006 with its every vulnerability and vanity exposed in the media glare nonetheless finishes in Pharm Exec's winner's circle once again. |
|
|
 Click here to find out about personnel movement in the Pharmaceutical industry | |
| |
| 
